Simpler Grants.gov #93.853

Forecasted NIH Grant for Collaborative Research on Neurodegeneration in ADRD

This opportunity is a forecasted research grant from the National Institutes of Health (NIH), specifically the National Institute of Neurological Disorders and Stroke (NINDS), focused on neurodegeneration in Alzheimer’s disease-related dementias (ADRD). - Government Buyer: - National Institutes of Health (NIH) - National Institute of Neurological Disorders and Stroke (NINDS) - No OEMs or commercial vendors are specified, as this is a research grant, not a product or service procurement. - Products/Services Requested: - Support for ambitious, interdisciplinary research projects investigating mechanisms of neurodegeneration in ADRD - Formation of a 'Center without Walls' consortium, uniting multiple institutions - Use of advanced technologies, disease-relevant models, clinical science, and human specimens - Identification of new therapeutic targets, biomarkers, and factors influencing ADRD susceptibility and pathology - One awardee will serve as a coordinating center for meetings, data harmonization, cross-site communication, and implementation of rigor and reproducibility plans - Unique/Notable Requirements: - Emphasis on collaboration across institutions and disciplines - Focus on foundational research to enable future translational and clinical studies - Informed by priorities from the ADRD Summit - No part numbers, quantities, or specific products/services are listed, as this is a grant forecast.

Description

The National Institute of Neurological Disorders and Stroke (NINDS) seeks to support ambitious research projects organized as a “Center without Walls” consortium to elucidate mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD). These collaborative research networks bring together diverse expertise from different institutions to tackle complex neurological problems. The program anticipates supporting interdisciplinary teams using multiple approaches, including advanced technologies and clinical science, to investigate disease mechanisms and identify therapeutic targets and biomarkers. One awardee will serve as a coordinating center to facilitate communication, data sharing, and implementation of rigor and reproducibility plans across awardees.

View original listing